Literature DB >> 2788004

Comparative analgesic and anti-inflammatory properties of sodium salicylate and acetylsalicylic acid (aspirin) in rheumatoid arthritis.

S J Preston1, M H Arnold, E M Beller, P M Brooks, W W Buchanan.   

Abstract

1. Enteric coated sodium salicylate 4.8 g daily was compared with the same dose of enteric coated aspirin in 18 patients with rheumatoid arthritis. 2. After an initial washout period lasting 3 days, patients were randomly allocated to treatment with sodium salicylate or aspirin. After 2 weeks the two treatments were crossed over. 3. Pain relief, reduction in articular index of joint tenderness, increase in grip strength, decrease in digital joint circumference and patients' assessment showed significant improvement with both treatments compared with the washout period. No significant differences were found between the two therapies. 4. No correlation was found in the degree of improvement in any of the clinical outcomes and the salicylate concentrations at steady state.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788004      PMCID: PMC1379926          DOI: 10.1111/j.1365-2125.1989.tb03423.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis.

Authors:  G G Graham; G D Champion; R O Day; P D Paull
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

2.  Comparative study of salsalate and aspirin in osteoarthrosis of the hip or knee.

Authors:  S P Liyanage; P K Tambar
Journal:  Curr Med Res Opin       Date:  1978       Impact factor: 2.580

3.  An assessment of grip strength measurement in rheumatoid arthritis.

Authors:  P Lee; A Baxter; W C Dick; J Webb
Journal:  Scand J Rheumatol       Date:  1974       Impact factor: 3.641

4.  Gastrointestinal blood loss from aspirin and sodium salicylate tablets in man.

Authors:  J R Leonards; G Levy
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

5.  Evaluation of digital joint circumference measurements in rheumatoid arthritis.

Authors:  J Webb; W W Downie; W C Dick; P Lee
Journal:  Scand J Rheumatol       Date:  1973       Impact factor: 3.641

6.  Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.

Authors:  A Szczeklik; R J Gryglewski; G Czerniawska-Mysik
Journal:  Br Med J       Date:  1975-01-11

7.  Prostaglandin synthetase activity from human rheumatoid synovial microsomes. Effect of 'aspirin-like' drug therapy.

Authors:  D Crook; A J Collins; P A Bacon; R Chan
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

8.  Gastrointestinal blood loss after diflunisal and after aspirin: effect of ethanol.

Authors:  P J DeSchepper; T B Tjandramaga; M De Roo; L Verhaest; C Daurio; S L Steelman; K F Tempero
Journal:  Clin Pharmacol Ther       Date:  1978-06       Impact factor: 6.875

9.  Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis.

Authors:  P M Brooks; J J Walker; W C Dick
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

10.  Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis.

Authors:  M Orme; P J Holt; G R Hughes; C J Bulpitt; G H Draffan; S S Thorgeirsson; F Williams; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

View more
  18 in total

Review 1.  AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels.

Authors:  D Grahame Hardie
Journal:  Annu Rev Nutr       Date:  2014-05-15       Impact factor: 11.848

Review 2.  Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Authors:  J Y Jouzeau; B Terlain; A Abid; E Nédélec; P Netter
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

Review 3.  Measuring the elastic modulus of soft culture surfaces and three-dimensional hydrogels using atomic force microscopy.

Authors:  Michael D A Norman; Silvia A Ferreira; Geraldine M Jowett; Laurent Bozec; Eileen Gentleman
Journal:  Nat Protoc       Date:  2021-04-14       Impact factor: 13.491

Review 4.  New insights into the mode of action of anti-inflammatory drugs.

Authors:  J R Vane; R M Botting
Journal:  Inflamm Res       Date:  1995-01       Impact factor: 4.575

5.  Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition.

Authors:  K Brune; W S Beck; G Geisslinger; S Menzel-Soglowek; B M Peskar; B A Peskar
Journal:  Experientia       Date:  1991-03-15

Review 6.  [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].

Authors:  D O Stichtenoth; H Zeidler; J C Frölich
Journal:  Med Klin (Munich)       Date:  1998-07-15

Review 7.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

8.  Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework.

Authors:  Yoshihiro Yamanishi; Masaaki Kotera; Minoru Kanehisa; Susumu Goto
Journal:  Bioinformatics       Date:  2010-06-15       Impact factor: 6.937

9.  AMPK: mediating the metabolic effects of salicylate-based drugs?

Authors:  Gregory R Steinberg; Madhumita Dandapani; D Grahame Hardie
Journal:  Trends Endocrinol Metab       Date:  2013-07-19       Impact factor: 12.015

Review 10.  Differential analgesic effects of aspirin-like drugs.

Authors:  K Brune; S Menzel-Soglowek; H U Zeilhofer
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.